172 related articles for article (PubMed ID: 26297470)
1. Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort.
Turner S; Bhurke S; Cook A
Health Res Policy Syst; 2015 Aug; 13():37. PubMed ID: 26297470
[TBL] [Abstract][Full Text] [Related]
2. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
[TBL] [Abstract][Full Text] [Related]
3. Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.
Wright D; Milne R; Price A; Tose N
Int J Technol Assess Health Care; 2013 Apr; 29(2):192-7. PubMed ID: 23552058
[TBL] [Abstract][Full Text] [Related]
4. The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study.
Wright D; Young A; Iserman E; Maeso R; Turner S; Haynes RB; Milne R
BMJ Open; 2014 May; 4(5):e004556. PubMed ID: 24812191
[TBL] [Abstract][Full Text] [Related]
5. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the impact of the NHS Health Technology Assessment Programme.
Hanney S; Buxton M; Green C; Coulson D; Raftery J
Health Technol Assess; 2007 Dec; 11(53):iii-iv, ix-xi, 1-180. PubMed ID: 18031652
[TBL] [Abstract][Full Text] [Related]
7. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
[TBL] [Abstract][Full Text] [Related]
8. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
[TBL] [Abstract][Full Text] [Related]
9. National Institute for Clinical Excellence (NICE). HTA rhyme and reason?
Taylor R
Int J Technol Assess Health Care; 2002; 18(2):166-70. PubMed ID: 12053416
[TBL] [Abstract][Full Text] [Related]
10. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
[TBL] [Abstract][Full Text] [Related]
11. Evidence-informed evidence-making.
Chalkidou K; Walley T; Culyer A; Littlejohns P; Hoy A
J Health Serv Res Policy; 2008 Jul; 13(3):167-73. PubMed ID: 18573766
[TBL] [Abstract][Full Text] [Related]
12. Time to publication for NIHR HTA programme-funded research: a cohort study.
Chinnery F; Young A; Goodman J; Ashton-Key M; Milne R
BMJ Open; 2013 Nov; 3(11):e004121. PubMed ID: 24285634
[TBL] [Abstract][Full Text] [Related]
13. Do the findings of case series studies vary significantly according to methodological characteristics?
Dalziel K; Round A; Stein K; Garside R; Castelnuovo E; Payne L
Health Technol Assess; 2005 Jan; 9(2):iii-iv, 1-146. PubMed ID: 15588556
[TBL] [Abstract][Full Text] [Related]
14. Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia.
Ball G; Levine MAH; Thabane L; Tarride JE
Curr Oncol; 2022 Oct; 29(10):7624-7636. PubMed ID: 36290879
[TBL] [Abstract][Full Text] [Related]
15. The impact of Cochrane Reviews: a mixed-methods evaluation of outputs from Cochrane Review Groups supported by the National Institute for Health Research.
Bunn F; Trivedi D; Alderson P; Hamilton L; Martin A; Pinkney E; Iliffe S
Health Technol Assess; 2015 Apr; 19(28):1-99, v-vi. PubMed ID: 25875129
[TBL] [Abstract][Full Text] [Related]
16. Synergy between health technology assessments and clinical guidelines for multiple sclerosis.
Hogervorst MA; Vreman RA; Zawada A; Zielińska M; Dawoud DM; de Jong BA; Mantel-Teeuwisse AK; Goettsch WG
Clin Transl Sci; 2023 May; 16(5):835-849. PubMed ID: 36855929
[TBL] [Abstract][Full Text] [Related]
17. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
[TBL] [Abstract][Full Text] [Related]
18. HTA'd in the USA: A Comparison of ICER in the United States with NICE in England and Wales.
Thokala P; Carlson JJ; Drummond M
J Manag Care Spec Pharm; 2020 Sep; 26(9):1162-1170. PubMed ID: 32857653
[TBL] [Abstract][Full Text] [Related]
19. Health technology assessment in the United Kingdom.
Drummond M; Banta D
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():178-81. PubMed ID: 19527538
[TBL] [Abstract][Full Text] [Related]
20. Data briefing. NICE (National Institute for Clinical Excellence).
Appleby J
Health Serv J; 2000 Jun; 110(5708):32. PubMed ID: 11183800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
